Nuvation Bio NUVB EPS (Diluted)
Discontinued — last reported Q1 '26
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvation Bio's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvation Bio's EPS (diluted)?
- Nuvation Bio (NUVB) reported EPS (diluted) of $0.01 in Q1 2026.
- How has Nuvation Bio's EPS (diluted) changed year-over-year?
- Nuvation Bio's EPS (diluted) increased by 106.3% year-over-year, from -$0.16 to $0.01.
- What is the long-term trend for Nuvation Bio's EPS (diluted)?
- Over 4 years (2021 to 2025), Nuvation Bio's EPS (diluted) has grown at a 8.1% compound annual growth rate (CAGR), from -$0.44 to -$0.60.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.